Efficacy and safety of 188 Re-HEDP in lung cancer patients with bone metastases: a randomized, multicenter, multiple-dose phase IIa study

Conclusions188Re-HEDP at dose of 40 and 50  MBq/kg was generally effective to alleviate pain and improve QOL in lung cancer patients with painful bone metastases.188Re-HEDP was safe and well-tolerated.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research